
What We’re Reading: Experts Advise on Pregnancy Drug; Novavax COVID-19 Booster Approved; Allergy Medication and Opioids
Experts advised the FDA to withdraw a preterm birth treatment from the market; the Novavax booster for COVID-19 was approved by US regulators on Wednesday; allergy medication was found to be commonly present in those who died of an opioid overdose.
Experts Recommend Withdrawing Preterm Birth Medication
A panel of experts voted 14-1 to recommend withdrawing hydroxyprogesterone caproate (Makena), a treatment intended to prevent preterm birth, from the market, according to
Novavax Booster Approved for Use
The FDA approved the Novavax COVID-19 booster to be used in adults 18 years and older, according to
Allergy Medication Could Contribute to Opioid Overdose Deaths
Allergy medications, such as antihistamines, could be involved in the death toll of the opioid epidemic, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.